Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Headline for Americans choking down a bucket of fried chicken with a “medical problem”.
Huh. Mine was hormonal.
Your bucket of fried chicken was hormonal?
it murica? yes
not even a joke
No, I’m dying.